Salivary microRNAs Show Potential as a Noninvasive Biomarker for Detecting Resectable Pancreatic Cancer
暂无分享,去创建一个
Bin Wu | Xiao‐Yu Yin | Bin Wu | Zijun Xie | Jian Huang | Bo Gong | Zijun Li | Zhiwei Zhou | Xiaoyu Yin | Wenjing Nie | Xuchao Zhang | Pingyou Zhang | Zijun Xie | Jian Huang | Zijun Li | Zhiwei Zhou | W. Nie | Pingyou Zhang | Bo Gong | Xuchao Zhang | Zhiwei Zhou
[1] Daniel F Hayes,et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] David Elashoff,et al. Salivary Transcriptome Diagnostics for Oral Cancer Detection , 2004, Clinical Cancer Research.
[3] C. Rosty,et al. Early detection of pancreatic carcinoma. , 2002, Hematology/oncology clinics of North America.
[4] J. Cheng,et al. High resolution of microRNA signatures in human whole saliva. , 2011, Archives of oral biology.
[5] David Elashoff,et al. Discovery and Preclinical Validation of Salivary Transcriptomic and Proteomic Biomarkers for the Non-Invasive Detection of Breast Cancer , 2010, PloS one.
[6] Q. Ma,et al. CA 19-9 and pancreatic cancer. , 2013, Clinical advances in hematology & oncology : H&O.
[7] J. K. Lee,et al. Clinical usefulness of carbohydrate antigen 19‐9 as a screening test for pancreatic cancer in an asymptomatic population , 2004, Journal of gastroenterology and hepatology.
[8] David Elashoff,et al. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. , 2010, Gastroenterology.
[9] G. Eibl,et al. Systemic Disease-Induced Salivary Biomarker Profiles in Mouse Models of Melanoma and Non-Small Cell Lung Cancer , 2009, PloS one.
[10] T. Homma,et al. CA19‐9 as a Screening and Diagnostic Tool in Symptomatic Patients: The Japanese Experience , 1994, Pancreas.
[11] David Elashoff,et al. Salivary protein factors are elevated in breast cancer patients. , 2008, Molecular medicine reports.
[12] Dongfeng Li,et al. Salivary MicroRNAs as Promising Biomarkers for Detection of Esophageal Cancer , 2013, PloS one.
[13] D. Wong,et al. Salivary diagnostics: moving to the next level. , 2012, Dentistry today.
[14] M. Tomita,et al. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles , 2009, Metabolomics.
[15] G. Illei,et al. MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndrome. , 2011, Arthritis and rheumatism.
[16] C. Balch,et al. AJCC Cancer Staging Manual. 6th ed , 2002 .
[17] D. Wong,et al. Saliva: an emerging biofluid for early detection of diseases. , 2009, American journal of dentistry.
[18] H. Friess,et al. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma , 2004, The British journal of surgery.
[19] A. Jemal,et al. Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.
[20] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[21] M. Duffy,et al. Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[22] U. Ballehaninna,et al. Serum CA 19-9 as a Biomarker for Pancreatic Cancer—A Comprehensive Review , 2011, Indian journal of surgical oncology.
[23] David Elashoff,et al. Development of transcriptomic biomarker signature in human saliva to detect lung cancer , 2012, Cellular and Molecular Life Sciences.
[24] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[25] John T McDevitt,et al. Current developments in salivary diagnostics. , 2010, Biomarkers in medicine.
[26] A. Vissink,et al. Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. , 2007, Arthritis and rheumatism.
[27] David S Ostreicher. Saving lives: toothbrushes trump seat belts. , 2012, Dentistry today.
[28] N. Park,et al. Salivary microRNA: Discovery, Characterization, and Clinical Utility for Oral Cancer Detection , 2009, Clinical Cancer Research.
[29] R. Molina,et al. CA 19–9 in pancreatic cancer: retrospective evaluation of patients with suspicion of pancreatic cancer , 2012, Tumor Biology.
[30] D. Chia,et al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer , 2011, Gut.
[31] Jae Hoon Kim,et al. Salivary transcriptomic biomarkers for detection of ovarian cancer: for serous papillary adenocarcinoma , 2011, Journal of Molecular Medicine.
[32] David Elashoff,et al. Discovery and Prevalidation of Salivary Extracellular microRNA Biomarkers Panel for the Noninvasive Detection of Benign and Malignant Parotid Gland Tumors , 2013, Clinical Cancer Research.
[33] Zijun Xie,et al. Saliva supernatant miR-21: a novel potential biomarker for esophageal cancer detection. , 2012, Asian Pacific journal of cancer prevention : APJCP.
[34] G. Illei,et al. Exosomes from human saliva as a source of microRNA biomarkers. , 2010, Oral diseases.
[35] David Elashoff,et al. Salivary Proteomics for Oral Cancer Biomarker Discovery , 2008, Clinical Cancer Research.
[36] Fuqiang Wen,et al. Diagnostic value of microRNA for pancreatic cancer: a meta-analysis , 2012, Archives of medical science : AMS.
[37] C. Croce. Introduction to the role of microRNAs in cancer diagnosis, prognosis, and treatment. , 2012, Cancer journal.